Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 9, keine Gesamtzahl für „Mylan“
Suchtreffer
Begriffe & Kennungen
Atazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 22 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration potential
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 23 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration Inhaled/Na
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 24 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration the active
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 25 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration dyslipidem
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 26 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration OPIOIDS Bu
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 27 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration intensive
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · 9 Medicinal products by Interaction Recommendations therapeutic area concerning co- administration Grazoprevir
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · A dose reduction of clarithromycin may result in subtherapeutic concentrations of 14-OH clarithromycin.
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Atazanavir AUC: ↑28% (↑16% ↑43%) Atazanavir Cmax : ↔6% (↓7% ↑20%) Atazanavir Cmin : ↑91% (↑66% ↑121%)
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Atazanavir concentrations were greatly decreased when co-administered with didanosine (buffered tablets) and s
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Atazanavir is an inhibitor of CYP3A4. The potential inhibition of P-gp by atazanavir is unknown and cannot be
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Atazanavir is metabolised in the liver through CYP3A4. It inhibits CYP3A4. Therefore, atazanavir is contraindi
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Co-administration of atazanavir with glecaprevir/pibrentasvir fixed-dose combination is contraindicated becaus
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Co-administration of atazanavir with grazoprevir-containing products, including elbasvir/grazoprevir fixed- do
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Concomitant use of Inhaled/Nasal Corticosteroids and atazanavir (with or without ritonavir) may increase plasm
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Effect on atazanavir and ritonavir exposure has not been studied. Expected: ↔ Atazanavir ↔ Ritonavir
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Elbasvir AUC: ↑376% (↑307% ↑456%) Elbasvir Cmax : ↑315% (↑246% ↑397%) Elbasvir Cmin : ↑545% (↑451% ↑654%)
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · Elbasvir concentrations were increased when co-administered with atazanavir/ritonavir. Sofosbuvir 400 mg / Sof
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · For co-administration of cutaneously administered corticosteroids sensitive to CYP3A inhibition, consult the S
Eintrag öffnenAtazanavir Viatris (previously Atazanavir Mylan) · 4.5 · If withdrawal of ritonavir is medically warranted under restrictive conditions (see section 4.4), special atte
Eintrag öffnen